Latest Publications

Share:

Antitrust Life Sciences Quarterly Update 2025 Q2

The first half of 2025 has seen an acceleration of M&A activity, including large-scale life sciences transactions, such as Merck’s $3.9 billion acquisition of SpringWorks, Sanofi’s $9.5 billion acquisition of Blueprint...more

Antitrust and Competition Life Sciences Year in Review 2024

The last year (and particularly the last few months) of the Biden Administration brought a flurry of activity from the Federal Trade Commission (FTC) in the life sciences space, continuing a yearslong pattern of close...more

In a Landmark Judgment, Top European Court Curbs European Commission’s Ability to Review “Killer Acquisitions”

On 3 September 2024, the European Court of Justice (ECJ) ruled that the European Commission (Commission) cannot encourage or accept referrals for below-threshold deals from national competition authorities if those...more

European Commission’s First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapy

The European Commission (EC) has launched a formal investigation under its abuse of dominance rules into US life sciences company Zoetis in the area of novel veterinary medicines. The EC alleges that the discontinuation of a...more

The Digital Markets, Competition, and Consumers Bill

The Digital Markets, Competition, and Consumers Bill (the DMCC) was introduced in the House of Commons on 25 April 2023, and the second reading was held on 17 May. The DMCC aims to cover two main topics: (a) digital markets...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide